Tag: immunosuppressive tumor microenvironment

In the relentless battle against cancer, the tumor microenvironment (TME) poses one of the most formidable barriers to effective immunotherapy. ...

In an era marked by rapid advancements in cancer research, a new player has emerged in the battle against glioblastoma, ...

In the relentless battle against cancer, one of the most formidable challenges remains bone metastases—the spreading of malignant cells to ...

In recent years, the quest to improve outcomes for glioblastoma (GB) patients has fueled intense research into novel therapeutic avenues, ...

In the rapidly evolving arena of oncology, hepatocellular carcinoma (HCC) stands as a formidable adversary, particularly when diagnosed at an ...

In a groundbreaking study published in the June 2025 issue of Oncotarget, researchers from multiple U.S. institutions have reported a ...

Recent Advances Reveal Radiotherapy’s Double-Edged Sword: Unveiling the Role of Amphiregulin in Tumour Metastasis Radiotherapy has long been a cornerstone ...

In a groundbreaking study poised to reshape our understanding of oral squamous cell carcinoma (OSCC), researchers have uncovered a distinctive ...

Emerging research from Ludwig Cancer Research’s Princeton branch unveils a pivotal mechanism by which advanced ovarian cancers subvert immune defenses, ...

In a groundbreaking advancement poised to reshape pancreatic cancer therapeutics, researchers at the Massachusetts Institute of Technology (MIT) and the ...